Evidence map›Paper›PMID 40913279›Full record

Trial reportJournal of the American Heart Association2025

Duration of Supervised Exercise Necessary for Meaningful Improvement in Peripheral Artery Disease.

Mary M McDermott, Dongxue Zhang, Lihui Zhao, Tamar Polonsky, Luigi Ferrucci, Karen J Ho, Melina R Kibbe, Jack M Guralnik, Michael H Criqui, Lu Tian

Registry-linked trialAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Journal of the American Heart Association, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01408901 (PROgenitor Cell Release Plus Exercise to Improve functionaL Performance in PAD), which is not on this map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01408901 nacompletednot on this map

PROgenitor Cell Release Plus Exercise to Improve functionaL Performance in PAD: The PROPEL Study

TypeinterventionalSponsorNorthwestern UniversityRan2011 to 2017Enrolled210ConditionsPeripheral Arterial DiseaseArmsSupervised Treadmill Exercise Therapy, Health education sessions (Control), granulocyte macrophage colony stimulating factor (GM-CSF)
3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Mary M McDermottDepartment of Internal Medicine Northwestern University Feinberg School of Medicine Chicago IL USA.ORCID 0000-0002-3724-7619
Dongxue ZhangDepartment of Internal Medicine Northwestern University Feinberg School of Medicine Chicago IL USA.ORCID 0000-0003-2912-2020
Lihui ZhaoDepartment of Preventive Medicine Northwestern University Feinberg School of Medicine Chicago IL USA.ORCID 0000-0002-6877-9490
Tamar PolonskyDepartment of Medicine University of Chicago Chicago IL USA.ORCID 0000-0003-2112-9244
Luigi FerrucciDivision of Intramural Research National Institute on Aging Baltimore MD USA.ORCID 0000-0002-6273-1613
Karen J HoDepartment of Surgery Northwestern University Feinberg School of Medicine Chicago IL USA.ORCID 0000-0002-7514-8953
Melina R KibbeDepartment of Surgery University of Virginia Health Charlottesville VA USA.ORCID 0000-0002-9049-4205
Jack M GuralnikDepartment of Epidemiology and Public Health University of Maryland School of Medicine Baltimore MD USA.ORCID 0000-0001-5108-7263
Michael H CriquiDepartment of Family Medicine and Public Health University of California San Diego La Jolla CA USA.ORCID 0000-0003-0425-9661
Lu TianDepartment of Health Research and Policy Stanford University Palo Alto CA USA.ORCID 0000-0002-5893-0169

Funding

PROgenitor Cell Release Plus Exercise To Improve Functional Performance In PADR01HL107510 · NHLBI · NORTHWESTERN UNIVERSITY AT CHICAGO · PI MCDERMOTT, MARY MCGRAE · 2011 to 2015
$5.6M
NHLBI NIH HHS R01 HL107510
6 · The paper itself

Abstract

backgroundSupervised treadmill exercise improves walking performance in people with lower extremity peripheral artery disease, but benefits are not immediate. This study identified the time course of attaining meaningful improvement in 6-minute walk distance and patient-reported outcome measures during a 6-month supervised exercise intervention in people with peripheral artery disease.

methodsParticipants with peripheral artery disease were randomized to supervised treadmill exercise 3 time weekly or a nonexercise control group for 6 months. Six-minute walk distance (large clinically important difference: 20 meters) and the Walking Impairment Questionnaire distance score (0-100 scale, 100 is best, clinically important difference: 5 points) were measured at the 6-week, 12-week, and 26-week follow-up using a mixed-effects model for repeated measures.

resultsOf 210 randomized participants (mean age, 67.0±8.6 years, 82 [39%] women, 141 [66%] Black), 200 (95%) completed at least 1 follow-up visit. Compared with controls, supervised exercise significantly improved 6-minute walk distance by 13.0 m (

conclusionsIn people with peripheral artery disease, >6 weeks of supervised treadmill exercise was necessary to attain a large meaningful gain in 6-minute walk, and large meaningful gains were measurable by week 12 of supervised exercise. Meaningful improvement in participant reported walking ability was first observed at the 12-week follow-up, but this statistically significant benefit was gone by the 26-week follow-up. REGISTRATION: URL: https://www.clinicaltrials.gov; Unique identifier: NCT01408901.

Indexed as

Exercise TherapyExercise TolerancePeripheral Arterial DiseaseWalkingAgedFemaleHumansMaleMiddle AgedPatient Reported Outcome MeasuresRecovery of FunctionTime FactorsTreatment OutcomeWalk Testintermittent claudicationperipheral artery diseasesupervised exercise

Identifiers

PMID40913279
PMCPMC12554396

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.